Advancing New Computer-based Health Outreach Regarding Sexual Behavior (ANCHORS) Study: UH3 Project

Summary

80 young adult men will complete an initial survey and receive 1 of 2 types of alcohol and sexual health education and information to encourage prevention of alcohol-related problems, HIV and other sexually transmitted infections (STIs). Participants will then take pre-exposure prophylaxis (PrEP) for HIV prevention and complete a daily 5-minute, telephone-based interactive voice response (IVR) assessment of alcohol/substance use, sexual behavior and PrEP taking for 30 days. Medication will all be active PrEP. There is no placebo control in this study. Follow-up will occur after 30-days and 6-months later.

Eligibility

Age range

18–30 years

Sex

Male

Healthy volunteers

Yes

Interventions

• Drug
  PrEP acronym (pre-exposure prophylaxis)

  A daily tablet containing 245 mg of tenofovir disoproxil fumarate and 200 mg emtricitabine (Truvada; Gilead Sciences) for up to 30 days.

• Behavioral
  Initial Web Survey

  Web-based assessment questions regarding alcohol and other substance use and sexual health behaviors

• Behavioral
  Interactive Voice Response (IVR) monitoring

  Daily telephone-based assessment on alcohol and other substance use, sexual health behavior and PrEP taking

• Behavioral
  Educational material on alcohol and sexual health behavior

  Educational material to provide information, resources and techniques to enhance awareness regarding alcohol and other substance use, along with sexual health behavior.

• Behavioral
  Interactive Voice Response (IVR) assessment with personalized information

  Daily telephone-based assessment on alcohol and other substance use, sexual health behavior and PrEP taking with personalized and information based on daily IVR responses

Location